Here, taking advantage of a potent Wnt inhibitor and a comprehensive transcriptomic analysis of a Wnt ligand–addicted orthotopic cancer model, we identified a core Wnt/β-catenin–repressed cholesterol biosynthesis enzyme, the 4-methyl sterol monooxidase FAXDC2, that controls this balance. This evidence concerns the gene FAXDC2 and cancer.